These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31602277)

  • 1. DNA methylation biomarkers in stool for early screening of colorectal cancer.
    Chen J; Sun H; Tang W; Zhou L; Xie X; Qu Z; Chen M; Wang S; Yang T; Dai Y; Wang Y; Gao T; Zhou Q; Song Z; Liao M; Liu W
    J Cancer; 2019; 10(21):5264-5271. PubMed ID: 31602277
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
    Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
    Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
    Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
    Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of quantifying
    Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
    Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.
    Zhang W; Yang C; Wang S; Xiang Z; Dou R; Lin Z; Zheng J; Xiong B
    Cancer Manag Res; 2021; 13():3601-3617. PubMed ID: 33958894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the clinical performance of
    Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W
    Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stool DNA Test of Methylated
    Niu F; Wen J; Fu X; Li C; Zhao R; Wu S; Yu H; Liu X; Zhao X; Liu S; Wang X; Wang J; Zou H
    Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1411-1419. PubMed ID: 28619831
    [No Abstract]   [Full Text] [Related]  

  • 8. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers.
    Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C
    Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
    Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
    Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
    BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is methylation analysis of
    Park SK; Baek HL; Yu J; Kim JY; Yang HJ; Jung YS; Choi KY; Kim H; Kim HO; Jeong KU; Chun HK; Kim K; Park DI
    Intest Res; 2017 Oct; 15(4):495-501. PubMed ID: 29142517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Biomarker-Combined Screening for Colorectal Cancer Based on Bisulfate Conversion-Free Detection of Fecal DNA Methylation.
    Liu C; Xu L; Li W; Jie M; Xue W; Yu W
    Biomed Res Int; 2021; 2021():1479748. PubMed ID: 34621892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening.
    Li B; Liu S; Gao Y; Zheng L; Lu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10241-10253. PubMed ID: 37270460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review.
    Anghel SA; Ioniță-Mîndrican CB; Luca I; Pop AL
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
    Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
    Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stool DNA methylation assays in colorectal cancer screening.
    Kadiyska T; Nossikoff A
    World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation profile of colon cancer genes in colorectal precursor lesions and tumor tissue: perspectives for screening.
    Sobanski T; Arantes LMRB; Dos Santos W; Matsushita M; de Oliveira MA; Costa M; de Carvalho AC; Berardinelli GN; Syrjänen K; Reis RM; Guimarães DP
    Scand J Gastroenterol; 2021 Aug; 56(8):920-928. PubMed ID: 34218733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
    Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
    BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test.
    Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H
    Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.